CrushSCI.com
提供学术论文选刊润色服务
npj Precision Oncology 期刊封面 医学
返回期刊列表

Review Cycle Records

npj Precision Oncology

Springer SCIE OA
2026新锐 1区2025中科院 1区 TOP2025 JCR Q1
201.5平均天数
205中位天数
117最短天数
308最长天数
4542025发文量

Paper Review Records

全部论文审稿周期

11 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

216 天

Minigene-based characterization and classification of splice-associated variants in succinate dehydrogenase B

作者Anni Köhler; Alexandra A. Baumann; Natasha Lewis; Anja Richter; Susan Richter; Doreen William; Andrés Cruz-García; Hanno Glimm; Stefan Fröhling; Diana Le Duc; Evelin Schröck; Arne Jahn

作者单位1. Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany; 2. National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; 3. ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany; 4. DKTK, Partner Site Dresden, Dresden, Germany; 5. Department of Systems Biology and Bioinformatics, University of Rostock, Rostock, Germany; 6. Institute for Medical Informatics and Biometry, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 7. Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Auckland, New Zealand; 8. Core Unit for Molecular Tumor Diagnostics (CMTD), NCT/UCC Dresden, a Partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; 9. Department for Translational Medical Oncology, National Center for Tumor Diseases (NCT/UCC) Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; 10. Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 11. Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 12. National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; 13. German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany; 14. Division of Translational Precision Medicine, Institute of Human Genetics, Heidelberg University, Heidelberg, Germany

PDF源文件 DOI 网页
248 天

A pancreatic cancer organoid-macrophage co-culture using starPEG-heparin hydrogel deciphers tumor-immune cell interactions

作者Julius Thyen; Victor A. Sioson; Daniel Haak; Beatrix Jahnke; Maximilian Fusenig; Abdul M. Aftab; Antonia Stammberger; Sascha Brückmann; Heike Polster; Stefanie Hübner; Verena J. Kast; Manuel Pfeifer; Rebecca Prause; Vivian Mittné; Carolin Beer; Malin H. Reinhart; Adrian M. Seifert; Lena Seifert; Martin Bornhäuser; Carsten Werner; Marc Schmitz; Daniela E. Aust; Jürgen Weitz; Daniela Loessner; Daniel E. Stange; Anna R. Poetsch; Mathieu Pecqueux; Franziska Baenke

作者单位1. Department of Visceral, Thoracic and Vascular Surgery, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 2. Leibniz Institute of Polymer Research Dresden, Max Bergmann Center of Biomaterials, Dresden, Germany; 3. Biomedical Genomics, Biotechnology Center, Center for Molecular and Cellular Bioengineering, TUD Dresden University of Technology, Dresden, Germany; 4. Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 5. Institute of Pathology and Tumor- and Normal Tissue Bank of the University Cancer Center (UCC), University Hospital Carl Gustav Carus, Medical Faculty, TUD Dresden University of Technology, Dresden, Germany; 6. Institute of Legal Medicine, Medizinische Fakultät, TUD Dresden University of Technology, Dresden, Germany; 7. Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases Dresden (NCT/UCC), Dresden, Germany; 8. National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; 9. German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; 10. Else Kröner Clinician Scientist Professor for Translational Tumor Immunological Research, TUD Dresden University of Technology, Dresden, Germany; 11. Medical Clinic I, University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 12. Center for Regenerative Therapies Dresden (CRTD) and Cluster of Excellence Physics of Life (PoL), TUD Dresden University of Technology, Dresden, Germany; 13. Department of Chemical and Biological Engineering and Department of Materials Science and Engineering, Faculty of Engineering, Monash University, Melbourne, Australia; 14. Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; 15. Institute for Genetics, University of Cologne, Cologne, Germany; 16. Cologne Excellence Cluster for Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany; 17. Institute for Genome Stability in Aging and Disease, University of Cologne, Cologne, Germany

PDF源文件 DOI 网页
171 天

Exploratory immunomonitoring during radiochemotherapy in HNSCC and machine-learning reveal immune parameters associated with disease-free survival

作者Anna-Jasmina Donaubauer; Oliver Tomic; Lia Mogge; Sarina K. Müller; Cecilia Marie Futsaether; Kristian Hovde Liland; Bao Ngoc Huynh; Jens von der Grün; Panagiotis Balermpas; Max Fleischmann; Matthias G. Hautmann; Felix Steger; Christopher Bohr; Thomas Hehr; Carmen Stromberger; Volker Budach; Markus Schymalla; Rita Engenhart-Cabillic; Lukas Kocik; Hans Geinitz; Ursula Nestle; Gunter Klautke; Claudia Scherl; Philipp Schubert; Stefanie Corradini; Rainer Fietkau; Udo S. Gaipl; Benjamin Frey; Marlen Haderlein

作者单位1. Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; 2. Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; 3. Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany; 4. Bavarian Cancer Research Center (BZKF), Erlangen, Germany; 5. Norwegian University of Life Sciences, Faculty of Science and Technology, Ås, Norway; 6. Department of Otolaryngology - Head & Neck Surgery, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; 7. Department of Medical Physics, Oslo University Hospital, Oslo, Norway; 8. Department of Radiation Oncology, Zurich University Hospital, Zurich, Switzerland; 9. Department of Radiotherapy and Radiation Oncology, University Hospital Frankfurt, Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany; 10. Department of Radiotherapy and Radiation Oncology, University Hospital of Regensburg, Regensburg, Germany; 11. Department of Otorhinolaryngology, University Hospital Regensburg, Regensburg, Germany; 12. Department of Radiotherapy and Radiation Oncology, Marienhospital, Stuttgart, Germany; 13. Department of Radiotherapy and Radiation Oncology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; 14. Department of Radiotherapy and Radiation Oncology, University Hospital of Marburg, Marburg, Germany; 15. Department of Radiation Oncology and Radiotherapy, Ordensklinikum Linz Barmherzige Schwestern, Linz, Austria; 16. Faculty of Medicine, Johannes Kepler University Linz, Linz, Austria; 17. Department of Radiotherapy and Radiation Oncology, Kliniken Maria Hilf, Moenchengladbach, Germany; 18. Department of Radiation Oncology, Chemnitz Hospital, Chemnitz, Germany; 19. Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany

PDF源文件 DOI 网页
193 天

High-grade serous ovarian cancer is associated with increased TP53 mutation burden in uterine lavage

作者Nicole Heinzl; Talayeh S. Ghezelayagh; Grace Wang; Brendan F. Kohrn; Ronit Katz; Coohleen Coombes; Thomas H. Smith; Zachary K. Norgaard; Fang Yin Lo; Elizabeth K. Schmidt; Jacob E. Higgins; Charles C. Valentine; Martin Filipits; Lou Romanens; Intidhar Labidi-Galy; Magdalena Postl; Christoph Grimm; David Cibula; Lukáš Dostálek; Filip Frühauf; Gabriel Jelenek; Magdalena Plch; Pavel Fabian; Alexander Mustea; Mateja Condic; Gunda Pristauz-Telsnigg; Karl Tamussino; Jiří Bouda; Christine E. Brambs; Sharon O’Toole; Katharina Bischof; Sabine Grill; Adam N. Rosenthal; Adriaan Vanderstichele; Peter Oppelt; T. Rinda Soong; Barbara M. Norquist; Jesse J. Salk; Robert Zeillinger; Paul Speiser; Rosa Ana Risques

作者单位1. Department of Obstetrics and Gynaecology, Comprehensive Cancer Center - Gynaecologic Cancer Unit, Medical University of Vienna, Vienna, Austria; 2. Department of Obstetrics & Gynecology, Stanford University, Palo Alto, USA; 3. Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA; 4. Department of Obstetrics and Gynecology, University of Washington, Seattle, USA; 5. TwinStrand Biosciences, Seattle, USA; 6. Center for Cancer Research, Medical University of Vienna, Vienna, Austria; 7. Department of Oncology, Hôpitaux Universitaires de Genève, Genève, Switzerland and Center of Translational Research in Onco-Hematology, Faculty of Medicine, Université de Genève, Genève, Switzerland; 8. Department of Obstetrics and Gynecology, First Faculty of Medicine and General University Hospital, Prague, Czech Republic; 9. Department of Surgical Oncology, Department of Gynaecological Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic; 10. Department of Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic; 11. Department of Gynecology and Gynecologic Oncology, University Hospital Bonn, Bonn, Germany; 12. Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria; 13. Faculty of Medicine, Charles University, Pilsen, Czech Republic; 14. Department of Obstetrics and Gynecology, Luzerner Kantonsspital, Luzern, Switzerland; 15. Department of Obstetrics and Gynaecology/Histopathology, Trinity St James’s Cancer Institute, Dublin, Ireland; 16. Department of Cancer Immunology, Institute for Cancer Research, University of Oslo, Oslo, Norway; 17. Department of Surgical Oncology, Section of Gynaecological Oncology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; 18. Department of Gynecology and Obstetrics, University Hospital of the TU, Munich, Germany; 19. Familial Cancer Clinic, Department of Gynaecology, University College London Hospitals NHS Trust, London, UK; 20. Department of Women’s Cancer, Elizabeth Garett Anderson Institute for Women’s Health, University College London, London, UK; 21. Department of Obstetrics and Gynecology, Catholic University Leuven, Leuven, Belgium; 22. Department of Gynaecology, Obstetrics, and Gynaecologic Endocrinology, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria; 23. Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, USA; 24. Division of Hematology and Oncology, University of Washington, Seattle, USA

PDF源文件 DOI 网页
148 天

Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarcinoma

作者Benjamin Heckelmann; Daniel Fetzner; Olga Lapshyna; Ashinikumar Singh Hidam; Annika Brauer; Anna Maxi Wandmacher; Benedikt Färber; Jannis Duhn; Meike ten Winkel; Louisa Bolm; Kim Honselmann; Steffen Deichmann; Christoph Röcken; Darko Carstven; Jens Marquardt; Corinna Keber; Timo Gemoll; Susanne Sebens; Tobias Keck; Ulrich Wellner; Rüdiger Braun

作者单位1. Department of Surgery, University of Luebeck, Luebeck, Germany; 2. Institute for Experimental Tumor Research, Kiel University, University Hospital Schleswig-Holstein, Kiel, Germany; 3. Department of Internal Medicine II, Division of Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany; 4. Department of Hematology and Oncology, University of Luebeck, Luebeck, Germany; 5. Institute of Pathology, Kiel University, University Hospital Schleswig-Holstein, Kiel, Germany; 6. Department of Internal Medicine I, University of Luebeck, Luebeck, Germany; 7. Institute of Pathology, University Hospital of Giessen-Marburg, Marburg, Germany

PDF源文件 DOI 网页
160 天

Comprehensive overview of AI methodologies in nano-drug delivery Optimization and Design

作者Lei Zhang; Jun Li; Mu Li; Lanlan Guo; Jing Zhang; Ling Liu; Zhenglun Yu

作者单位1. Department of Breast Surgery, The First Hospital of China Medical University, Shenyang, China; 2. Department of Ophthalmology, The First Hospital of China Medical University, Shenyang, China; 3. Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, China; 4. Department of Ultrasound, The Fourth Affiliated Hospital of China Medical University, Shenyang, China; 5. Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China; 6. Department of Gynecology, The Fourth Affiliated Hospital of China Medical University, Shenyang, China; 7. Department of Thoracic Surgery, The First Hospital of China Medical University, Shenyang, China

PDF源文件 DOI 网页
205 天

The phosphoproteome of ovarian carcinoma delineates signaling signatures and potentially druggable targets across histotype stages

作者Lucas Werner; Parisa Esmaeili; Ella Ittner; Hugo Swenson; Anikó Kovács; Claudia Mateoiu; Pernilla Dahm-Kähler; Per Karlsson; Toshima Parris; Fredrik Levander; Khalil Helou

作者单位1. Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 2. Sahlgrenska Center for Cancer Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 3. Department of Immunotechnology, Science for Life Laboratory, Lund University, Lund, Sweden; 4. Department of Clinical Pathology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden; 5. Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 6. Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 7. Department of Oncology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden

PDF源文件 DOI 网页
308 天

Durable clinical and immunologic response to an off-the-shelf EWSR1–FLI1 peptide vaccine in metastatic Ewing sarcoma

作者Branko Calukovic; Katrin Benzler; Henning Zelba; Christian Seitz; Simone Kayser; Magdalena Feldhahn; Borong Shao; Martin Schulze; Olga Maksimovic; Veit Scheble; Florian Battke; Lars Zender; Ulrich M. Lauer; Saskia Biskup; Christoph K. W. Deinzer

作者单位1. Department of Internal Medicine VIII - Medical Oncology and Pneumology, University Hospital Tübingen, Tübingen, Germany; 2. Center for Soft Tissue Sarcomas, GIST and Bone Tumors (ZWS) of the University Hospital Tübingen and the Comprehensive Cancer Center (CCC) Tübingen-Stuttgart, Tübingen, Germany; 3. DFG Cluster of Excellence 2180 ‘Image-Guided and Functional Instructed Tumor Therapy’ (iFIT), University of Tübingen, Tübingen, Germany; 4. Center for Human Genetics Tübingen, Tübingen, Germany; 5. Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ), Heidelberg, Germany; 6. Department of Pediatric Oncology, Hematology, and Immunology, Heidelberg University Hospital, Heidelberg, Germany; 7. Department of General Pediatrics, Hematology and Oncology, University Children’s Hospital, Tübingen, Germany; 8. CeGaT GmbH, Tübingen, Germany; 9. MVZ Oncology Tübingen, Tübingen, Germany; 10. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Tübingen, Germany

PDF源文件 DOI 网页
117 天

Functional profiling of ovarian cancer models reveals Bcl-xL/NOTCH targeting to overcome resistance

作者Greta Gudoityte; Olena Berkovska; Lukas M. Orre; Elisabeth Moussaud-Lamodière; Rebecka Bergström; Johan Lindberg; Martin Haraldsson; Sacha Bou Nafeh; Méline Louhaur; Olli Kallioniemi; Josefin Fernebro; Ulrika Joneborg; Brinton Seashore-Ludlow

作者单位1. Science for Life Laboratory (SciLifeLab), Karolinska Institutet, Stockholm, Sweden; 2. Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; 3. Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden; 4. Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden; 5. Department of Molecular Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 6. Chemical Biology Consortium Sweden, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden; 7. Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; 8. Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden; 9. Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden

PDF源文件 DOI 网页
217 天

Patient cell drug profiling identifies p53-linked vulnerabilities in refractory lymphoid malignancies

作者Arvid Cederlund; Nona Struyf; Lucia Rico Pizarro; Päivi Östling; Kristina Sonnevi; Björn Engelbrekt Wahlin; Tom Erkers

作者单位1. Dept. of Medicine at Huddinge, Karolinska Institutet, Stockholm, Sweden; 2. Medical Unit Hematology at Solna, Cancer, Karolinska University Hospital, Stockholm, Sweden; 3. Department of Oncology-Pathology, Karolinska Institutet and Science for Life Laboratory, Stockholm, Sweden

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。